Integrating NGS Proteomics with Genomics to Improve Immunotherapy Outcomes in Oncology

Learn how to integrate next-generation sequencing (NGS) proteomics with genomics to enhance immunotherapy outcomes in cancer treatment through this 36-minute webinar. Discover the critical role of predictive and prognostic biomarkers in improving cancer therapy effectiveness, with a focus on a Phase III clinical trial that utilized the Olink® Explore 3072 proteomics platform. Explore how researchers identified a unique 15-protein signature that successfully predicts patient response to chemotherapy treatment, where patients with higher signature scores demonstrated longer survival rates and improved treatment outcomes. Examine the integration of genomics data that revealed specific gene mutations and pathways correlated with enhanced treatment response. Gain insights into multi-omics workflows and their applications in oncology research, including strain identification, viral vector integration site analysis, and gene editing off-target effect evaluation that support preclinical research for CAR-T, iPSC, and other cell therapy products.